Citadel Advisors’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-20,600
| Closed | -$627K | – | 13675 |
|
|
2025
Q3 | $627K | Buy |
+20,600
| New | +$633K | ﹤0.01% | 8584 |
|
|
2025
Q2 | – | Sell |
-9,600
| Closed | -$336K | – | 14339 |
|
|
2025
Q1 | $336K | Buy |
9,600
+2,800
| +41% | +$111K | ﹤0.01% | 9330 |
|
|
2024
Q4 | $303K | Sell |
6,800
-6,200
| -48% | -$278K | ﹤0.01% | 9641 |
|
|
2024
Q3 | $567K | Buy |
13,000
+3,700
| +40% | +$139K | ﹤0.01% | 7990 |
|
|
2024
Q2 | $252K | Buy |
9,300
+4,900
| +111% | +$142K | ﹤0.01% | 9482 |
|
|
2024
Q1 | $129K | Sell |
4,400
-5,400
| -55% | -$164K | ﹤0.01% | 11002 |
|
|
2023
Q4 | $369K | Sell |
9,800
-5,900
| -38% | -$217K | ﹤0.01% | 8732 |
|
|
2023
Q3 | $707K | Buy |
15,700
+6,700
| +74% | +$406K | ﹤0.01% | 7316 |
|
|
2023
Q2 | $663K | Sell |
9,000
-13,300
| -60% | -$897K | ﹤0.01% | 7312 |
|
|
2023
Q1 | $1.31M | Buy |
22,300
+14,400
| +182% | +$794K | ﹤0.01% | 6220 |
|
|
2022
Q4 | $398K | Buy |
7,900
+5,400
| +216% | +$324K | ﹤0.01% | 8725 |
|
|
2022
Q3 | $218K | Sell |
2,500
-4,100
| -62% | -$431K | ﹤0.01% | 10241 |
|
|
2022
Q2 | $751K | Sell |
6,600
-1,200
| -15% | -$138K | ﹤0.01% | 7689 |
|
|
2022
Q1 | $1.01M | Sell |
7,800
-33,500
| -81% | -$4.83M | ﹤0.01% | 7671 |
|
|
2021
Q4 | $7.45M | Buy |
41,300
+30,100
| +269% | +$5.22M | ﹤0.01% | 3599 |
|
|
2021
Q3 | $1.66M | Sell |
11,200
-3,700
| -25% | -$567K | ﹤0.01% | 6835 |
|
|
2021
Q2 | $2.26M | Buy |
14,900
+1,300
| +10% | +$181K | ﹤0.01% | 6291 |
|
|
2021
Q1 | $1.77M | Buy |
13,600
+10,800
| +386% | +$1.39M | ﹤0.01% | 6705 |
|
|
2020
Q4 | $336K | Sell |
2,800
-21,400
| -88% | -$2.1M | ﹤0.01% | 8874 |
|
|
2020
Q3 | $1.81M | Buy |
24,200
+19,500
| +415% | +$1.35M | ﹤0.01% | 4906 |
|
|
2020
Q2 | $332K | Buy |
+4,700
| New | +$322K | ﹤0.01% | 7755 |
|
|
2019
Q4 | – | Sell |
-5,100
| Closed | -$369K | – | 9552 |
|
|
2019
Q3 | $369K | Buy |
5,100
+1,400
| +38% | +$103K | ﹤0.01% | 7251 |
|
|
2019
Q2 | $318K | Buy |
3,700
+900
| +32% | +$73.1K | ﹤0.01% | 7496 |
|
|
2019
Q1 | $226K | Sell |
2,800
-8,100
| -74% | -$606K | ﹤0.01% | 8041 |
|
|
2018
Q4 | $668K | Buy |
10,900
+7,500
| +221% | +$508K | ﹤0.01% | 5950 |
|
|
2018
Q3 | $244K | Sell |
3,400
-2,200
| -39% | -$139K | ﹤0.01% | 7914 |
|
|
2018
Q2 | $294K | Sell |
5,600
-1,400
| -20% | -$65.8K | ﹤0.01% | 7244 |
|
|
2018
Q1 | $304K | Buy |
7,000
+1,700
| +32% | +$78.2K | ﹤0.01% | 6728 |
|
|
2017
Q4 | $257K | Buy |
+5,300
| New | +$267K | ﹤0.01% | 6698 |
|
|
2016
Q1 | – | Sell |
-6,200
| Closed | -$193K | – | 7617 |
|
|
2015
Q4 | $193K | Sell |
6,200
-2,100
| -25% | -$62K | ﹤0.01% | 5851 |
|
|
2015
Q3 | $258K | Buy |
8,300
+2,200
| +36% | +$78.8K | ﹤0.01% | 5785 |
|
|
2015
Q2 | $230K | Buy |
6,100
+3,700
| +154% | +$135K | ﹤0.01% | 6133 |
|
|
2015
Q1 | $84K | Buy |
+2,400
| New | +$79.1K | ﹤0.01% | 6986 |
|
|
2014
Q1 | – | Sell |
-2,000
| Closed | -$51K | – | 7966 |
|
|
2013
Q4 | $51K | Sell |
2,000
-3,400
| -63% | -$81.2K | ﹤0.01% | 6022 |
|
|
2013
Q3 | $128K | Buy |
5,400
+5,100
| +1,700% | +$114K | ﹤0.01% | 5162 |
|
|
2013
Q2 | $6K | Buy |
+300
| New | +$5.54K | ﹤0.01% | 6327 |
|
Other funds holding OMCL
VPM
VCM
NAMI
Citadel Advisors's OMCL Position: Q1 2026 in Review
Citadel Advisors sold out of Omnicell (OMCL) in Q1 2026, closing a stake of 252,062 shares — an estimated $11.4M sold.
Citadel Advisors first reported a position in OMCL in Q2 2013 and held it in 39 quarters. The position peaked at $30.2M in Q3 2022. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.
- Citadel Advisors reported no remaining Omnicell position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 252,062 Omnicell shares in Q1 2026, an estimated $11.4M.
- Citadel Advisors first reported a position in Omnicell in Q2 2013 and held it in 39 quarters.
- Citadel Advisors's Omnicell position peaked at $30.2M in Q3 2022.
- 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.